Tirzepatide 30 mg

TZ-2026-031Lot DRC-TR30-1027Analyzed November 2, 2026

Timeline

Ordered

October 28, 2026

Received

October 31, 2026

Analyzed

November 2, 2026

Sample

Name

Tirzepatide 30 mg

Expected

Tirzepatide

Amount

1 vial, lyophilized powder

Testing

Client

Dynasty Research Co

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

32.16mg

Label claim: 30 mg

Purity, how clean it is

>99.9%

by HPLC-UV peak area

Chromatogram

HPLC-UV

18.93 min, Tirzepatide, >99.9%

Analyst Comments

White lyophilized powder, yellow-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: November 2, 2026

Verification Code

TZ-17MO-V3FR

Verify at purilab.org/verify/TZ-17MO-V3FR

Scan to Verify

TZ-17MO-V3FR

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1